Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

xylem inc. - XYL

XYL

Close Chg Chg %
122.48 -1.20 -0.98%

Closed Market

121.29

-1.20 (0.98%)

Volume: 1.44M

Last Updated:

Apr 2, 2026, 3:59 PM EDT

Trade Now

Company Overview: xylem inc. - XYL

XYL Key Data

Open

$120.14

 Day Range

118.93 - 122.58

52 Week Range

100.47 - 154.24

 Market Cap

$29.48B

Shares Outstanding

243.14M

 Public Float

242.50M

Beta

1.17

 Rev. Per Employee

N/A

P/E Ratio

30.92

 EPS

$3.93

Yield

134.42%

 Dividend

$0.43

EX-DIVIDEND DATE

Feb 24, 2026

 SHORT INTEREST

N/A

AVERAGE VOLUME

1.92M

  

XYL Performance

1 Week
 
 3.16%
 
1 Month
 
 -1.53%
 
3 Months
 
 -11.56%
 
1 Year
 
 15.93%
 
5 Years
 
 15.88%
 

XYL Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 25
Full Ratings ➔

About xylem inc. - XYL

Xylem, Inc. engages in the design, manufacture, and application of engineered technologies for the water industry. It operates through the following business segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment focuses on the transportation, treatment and testing of water. The Applied Water segment encompasses the uses of water and focuses on the commercial, residential, and industrial end markets. The Measurement and Control Solutions segment focuses on developing technology solutions that enable intelligent use and conservation of critical water and energy resources as well as analytical instrumentation used in the testing of water. The company was founded in 2011 and is headquartered in Washington, DC.

XYL At a Glance

Xylem, Inc.
301 Water Street SE
Washington, District of Columbia 20003
Phone 1-202-869-9150 Revenue 9.03B
Industry Industrial Machinery Net Income 957.00M
Sector Producer Manufacturing 2025 Sales Growth 5.465%
Fiscal Year-end 12 / 2026 Employees 22,000
View SEC Filings

XYL Valuation

P/E Current 30.916
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 34.72
Price to Sales Ratio 3.679
Price to Book Ratio 2.889
Price to Cash Flow Ratio 26.77
Enterprise Value to EBITDA 18.248
Enterprise Value to Sales 3.823
Total Debt to Enterprise Value 0.073

XYL Efficiency

Revenue/Employee 410,500.00
Income Per Employee 43,500.00
Receivables Turnover 5.134
Total Asset Turnover 0.529

XYL Liquidity

Current Ratio 1.625
Quick Ratio 1.281
Cash Ratio 0.518

XYL Profitability

Gross Margin 38.379
Operating Margin 14.583
Pretax Margin 13.077
Net Margin 10.597
Return on Assets 5.608
Return on Equity 8.652
Return on Total Capital 6.841
Return on Invested Capital 7.316

XYL Capital Structure

Total Debt to Total Equity 21.855
Total Debt to Total Capital 17.936
Total Debt to Total Assets 14.228
Long-Term Debt to Equity 15.854
Long-Term Debt to Total Capital 13.01
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Xylem Inc. - XYL

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
5.54B 7.37B 8.56B 9.03B
Sales Growth
+6.58% +32.95% +16.23% +5.47%
Cost of Goods Sold (COGS) incl D&A
3.44B 4.64B 5.35B 5.57B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
236.00M 436.00M 562.00M 575.00M
Depreciation
111.00M 193.00M 258.00M 267.00M
Amortization of Intangibles
125.00M 243.00M 304.00M 308.00M
COGS Growth
+6.71% +35.13% +15.21% +4.04%
Gross Income
2.10B 2.72B 3.21B 3.47B
Gross Income Growth
+6.37% +29.41% +17.99% +7.84%
Gross Profit Margin
+37.99% +36.98% +37.53% +38.38%
2022 2023 2024 2025 5-year trend
SG&A Expense
1.44B 1.99B 2.14B 2.15B
Research & Development
206.00M 232.00M 230.00M 226.00M
Other SG&A
1.23B 1.76B 1.91B 1.92B
SGA Growth
+4.12% +38.13% +7.64% +0.37%
Other Operating Expense
- - - -
-
Unusual Expense
140.00M 46.00M 30.00M 61.00M
EBIT after Unusual Expense
525.00M 689.00M 1.04B 1.26B
Non Operating Income/Expense
(6.00M) 25.00M 120.00M (4.00M)
Non-Operating Interest Income
16.00M 28.00M 28.00M 27.00M
Equity in Earnings of Affiliates
- - (4.00M) 2.00M
-
Interest Expense
79.00M 79.00M 76.00M 71.00M
Interest Expense Growth
- -18.56% -3.80% -6.58%
Gross Interest Expense
79.00M 79.00M 76.00M 71.00M
Interest Capitalized
- - - -
-
Pretax Income
440.00M 635.00M 1.09B 1.18B
Pretax Income Growth
-13.89% +44.32% +71.18% +8.65%
Pretax Margin
+7.94% +8.62% +12.69% +13.08%
Income Tax
85.00M 26.00M 197.00M 231.00M
Income Tax - Current - Domestic
93.00M 19.00M 143.00M 158.00M
Income Tax - Current - Foreign
56.00M 86.00M 90.00M 108.00M
Income Tax - Deferred - Domestic
(55.00M) (57.00M) (49.00M) (37.00M)
Income Tax - Deferred - Foreign
(9.00M) (22.00M) 13.00M 2.00M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - (4.00M) 2.00M
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
355.00M 609.00M 890.00M 950.00M
Minority Interest Expense
- - - (7.00M)
-
Net Income
355.00M 609.00M 890.00M 957.00M
Net Income Growth
-16.86% +71.55% +46.14% +7.53%
Net Margin Growth
+6.41% +8.27% +10.39% +10.60%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
355.00M 609.00M 890.00M 957.00M
Preferred Dividends
- - - -
-
Net Income Available to Common
355.00M 609.00M 890.00M 957.00M
EPS (Basic)
1.9698 2.8063 3.6688 3.9324
EPS (Basic) Growth
-16.85% +42.47% +30.73% +7.18%
Basic Shares Outstanding
180.22M 217.01M 242.58M 243.37M
EPS (Diluted)
1.9616 2.7913 3.6547 3.9222
EPS (Diluted) Growth
-16.61% +42.30% +30.93% +7.32%
Diluted Shares Outstanding
180.98M 218.18M 243.52M 243.99M
EBITDA
901.00M 1.17B 1.64B 1.89B
EBITDA Growth
+7.13% +29.97% +39.62% +15.72%
EBITDA Margin
+16.26% +15.90% +19.09% +20.95%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 159.688
Number of Ratings 25 Current Quarters Estimate 1.356
FY Report Date 06 / 2026 Current Year's Estimate 5.504
Last Quarter’s Earnings 1.09 Median PE on CY Estimate N/A
Year Ago Earnings 5.08 Next Fiscal Year Estimate 6.072
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 19 19 21 21
Mean Estimate 1.36 1.45 5.50 6.07
High Estimates 1.40 1.50 5.57 6.40
Low Estimate 1.32 1.41 5.40 5.85
Coefficient of Variance 2.05 1.64 0.85 2.35

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 14 14 14
OVERWEIGHT 3 3 3
HOLD 8 8 8
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Xylem Inc. - XYL

Date Name Shares Transaction Value
Mar 4, 2026 Rodney O. Aulick EVP & President, WSS 73,917 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $128.98 per share 9,533,814.66
Mar 4, 2026 Meredith Emmerich EVP & Pres, AW 5,739 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 4, 2026 Hayati Yarkadas EVP & President, WI 33,581 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $128.98 per share 4,331,277.38
Mar 4, 2026 Hayati Yarkadas EVP & President, WI 33,698 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $128.98 per share 4,346,368.04
Mar 4, 2026 Hayati Yarkadas EVP & President, WI 33,792 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $128.98 per share 4,358,492.16
Mar 4, 2026 Hayati Yarkadas EVP & President, WI 34,357 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 4, 2026 Hayati Yarkadas EVP & President, WI 32,083 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $128.98 per share 4,138,065.34
Mar 4, 2026 Hayati Yarkadas EVP & President, WI 30,322 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $128.98 per share 3,910,931.56
Mar 4, 2026 Hayati Yarkadas EVP & President, WI 27,821 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $128.98 per share 3,588,352.58
Mar 4, 2026 Hayati Yarkadas EVP & President, WI 24,142 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $128.98 per share 3,113,835.16
Mar 4, 2026 Rodney O. Aulick EVP & President, WSS 5,739 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 4, 2026 Claudia S. Toussaint EVP, CPSO 6,299 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $128.98 per share 812,445.02
Mar 4, 2026 Rodney O. Aulick EVP & President, WSS 74,155 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 4, 2026 Claudia S. Toussaint EVP, CPSO 7,089 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 4, 2026 Claudia S. Toussaint EVP, CPSO 9,342 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $128.98 per share 1,204,931.16
Mar 4, 2026 Claudia S. Toussaint EVP, CPSO 9,944 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $128.98 per share 1,282,577.12
Mar 4, 2026 Claudia S. Toussaint EVP, CPSO 10,741 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $128.98 per share 1,385,374.18
Mar 4, 2026 Claudia S. Toussaint EVP, CPSO 13,321 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 4, 2026 Claudia S. Toussaint EVP, CPSO 11,332 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $128.98 per share 1,461,601.36
Mar 4, 2026 Claudia S. Toussaint EVP, CPSO 9,571 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $128.98 per share 1,234,467.58

Xylem Inc. in the News